公司概覽
業務類別 Medical Instruments & Supplies
業務概覽 Following the separation of the life science segment, Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
公司地址 1 Becton Drive, Franklin Lakes, NJ, USA, 07417-1880
電話號碼 +1 201 847-6800
傳真號碼 --
公司網頁 http://www.bd.com
員工數量 72000
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Thomas E. Polen, Jr Chairman of the Board, Chief Executive Officer and President 美元 1.40M 18/12/2025
Mr. Roland Goette Executive Vice President and President, EMEA -- 25/11/2025
Mr. Bilal Muhsin Executive Vice President and President, Connected Care Segment -- 25/11/2025
Ms. Shana Carol Neal Executive Vice President and Chief People Officer -- 25/11/2025
Mr. Antoine C. Ezell Executive Vice President, President, North America and Chief Marketing Officer -- 25/11/2025
Mr. Pavan Kumar Mocherla Executive Vice President and President, Greater Asia -- 25/11/2025
Mr. David Shan Executive Vice President and Chief Integrated Supply Chain Officer -- 25/11/2025
Ms. Michelle Quinn Executive Vice President and General Counsel -- 27/11/2024
Ms. Pamela L. Spikner Senior Vice President, Chief Accounting Officer and Controller -- 25/11/2025
Mr. Michael Feld Executive Vice President and President, Life Sciences 美元 775.00K 25/11/2025
Mr. Vitor Roque Senior Vice President of Finance, Business Units, Corporate Financial Planning, Analysis and Interim Chief Financial Officer -- 15/10/2025
 
董事會成員
董事會 職務 更新日期
Mr. Bertram L. Scott Lead Independent Director 18/12/2025
Mr. Timothy M. Ring Independent Director 18/12/2025
Mr. William M. Brown Independent Director 18/12/2025
Mr. Gregory J. Hayes Independent Director 18/12/2025
Mr. Jeffrey W. Henderson Independent Director 18/12/2025
Mr. R. Andrew Eckert Independent Director 18/12/2025
Mr. Christopher Ian Montague Jones Independent Director 18/12/2025
Mr. Thomas E. Polen, Jr Chairman of the Board, Chief Executive Officer and President 18/12/2025
Ms. Jacqueline Wright Independent Director 17/11/2025
Dr. Carrie L. Byington Independent Director 18/12/2025
Dr. Joanne Waldstreicher, M.D. Independent Director 18/12/2025
Mr. Robert L. Huffines Independent Director 17/11/2025
 
所屬ETF (更新日期: 07/11/2026 02:32)
代號 名稱 佔比% ▼ 持有日期
JPUSJPMorgan Diversified Return US Eq ETF0.004%30/10/2026
QVMLInvesco S&P 500 QVM Multi-factor ETF0.004%30/10/2026
UCBGState Street(R) SPDR(R)UIn90/10EdStIdETF0.003%30/10/2026
DFSUDimensional US Sustainability Core 1 ETF0.003%30/10/2026
GUSAGoldman Sachs MarketBeta US 1000 Eq ETF0.003%30/10/2026
KLMTInvesco MSCI Global Climate 500 ETF0.003%30/10/2026
FNDBSchwab Fundamental U.S. Broad Market ETF0.003%31/10/2026
EQINColumbia US Equity Income ETF0.003%31/10/2026
GRXGabelli Health & Wellness0.003%30/06/2026
USPXFranklin US Equity Index ETF0.003%31/10/2026
HTECRobo Global® Hlthcare Tech & Innovt ETF0.003%30/10/2026
DFALDimensional US Large Cp Cor Eq Mkt ETF0.003%30/10/2026
PFMInvesco Dividend Achievers™ ETF0.003%30/10/2026
FEXFirst Trust Large Cap Core AlphaDEX® ETF0.003%29/10/2026
TALVTransamerica Large Value Active ETF0.003%30/10/2026
ONEVStt Strt® SPDR® Russell 1000 LwVolFocETF0.003%30/10/2026
TILTNorthern Trust Mstar US Mkt Fac Tlt ETF0.003%30/10/2026
EFIVState Street SPDR S&P500 Scrd&ScrndETF0.003%30/10/2026
GSPYGotham Enhanced 500 ETF0.003%30/10/2026
QDPLPacer Metaurus US Lg Cp Dvd Mltp 400 ETF0.003%30/10/2026
  1    2    3    4    5    6    7   8    9    10    11    12    13    14    15    16    17  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.